当前位置: X-MOL 学术JACC Heart Fail. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cause-Specific Health Care Costs Following Hospitalization for Heart Failure and Cost Offset With SGLT2i Therapy
JACC: Heart Failure ( IF 10.3 ) Pub Date : 2024-04-06 , DOI: 10.1016/j.jchf.2024.04.003
Veraprapas Kittipibul 1 , Muthiah Vaduganathan 2 , Uchechukwu Ikeaba 3 , Karen Chiswell 3 , Javed Butler 4 , Adam D DeVore 1 , Paul A Heidenreich 5 , Joanna C Huang 6 , Michelle M Kittleson 7 , Karen E Joynt Maddox 8 , Karthik K Linganathan 6 , James J McDermott 6 , Anjali Tiku Owens 9 , Pamela N Peterson 10 , Scott D Solomon 11 , Orly Vardeny 12 , Clyde W Yancy 13 , Gregg C Fonarow 14 , Stephen J Greene 1
Affiliation  

Little is known regarding differences in cause-specific costs between heart failure (HF) with ejection fraction (EF) ≤40% vs >40%, and potential cost implications of sodium glucose co-transporter 2 inhibitor (SGLT2i) therapy.

中文翻译:


因心力衰竭住院后的特定原因医疗保健费用以及 SGLT2i 治疗的费用抵消



关于射血分数 (EF) ≤ 40% 的心力衰竭 (HF) 与 >40% 之间的特定原因成本差异以及钠葡萄糖协同转运蛋白 2 抑制剂 (SGLT2i) 治疗的潜在成本影响,人们知之甚少。
更新日期:2024-04-06
down
wechat
bug